Proqr therapeutics n.v.

Major-Pharmaceuticals

PRQR


Zernikedreef 9
Leiden , 2333 Ck

Executive/
Director

Price

  • Last Close
  • $ 3.45
    $ +1.46 73.37 %
    Dec 9, 2024
  • 52-Week High/Low
  • $2.85 - $1.15
  • YTD
  • 74.2%

  • Trading Volume
  • 12,394
  • Market Cap Full
  • $ 278.8M
  • Shares Outstanding
  • 80.8M
    Dec 31, 2022
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 1% -43.8% 2% -4.6% -12.1% -5% 57.4% -88.4% -42.4% 14.7%
Q2 -23.8% -0.8% 4% 147.5% -36.6% 4% 2% -16.2% -23.9% -
Q3 -12.6% 37.8% -6.7% 166.9% -36.9% 8% 24.2% -4.4% -19.8% -
Q4 -40.4% -26.5% -32.7% -22% 63.8% -12.3% -4.3% 397.3% 58.4% -
J F M A M J J A S O N D
2024 9.6% -7.1% 12.7% -3.5% - - - - - - - -
2023 -25.4% 6.9% -27.8% 2.4% -20.2% -6.9% -7.4% 6% -18.2% -11.5% 34.8% 27.7%
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    0%-60%-44%-34%389%-40%-56%91%-54%-46%74%

Earnings

2015 2016 2017 2018 2019 2020 2021 2022 2023
Q1 0.01 0.48 0.48 -0.42 -0.41 -0.35 -0.3 -0.22 -0.12
Q2 0.41 0.48 0.52 -0.27 -0.34 -0.09 -0.29 -0.22 -0.11
Q3 0.30 0.48 0.49 -0.21 -0.34 -0.3 -0.26 -0.34 -0.08
Q4 0.29 0.41 0.46 -0.37 -0.45 -0.32 -0.29 -0.17 -
A 1 1.9 2 -1.3 -1.5 -1.1 -1.1 -1 -0.31

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022
Mar - - - - -
Jun - - - - -
Sep - - - - -
Dec 38.9 49.7 54.1 71.3 80.8

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover 0.2 0.1 - - -
Total Asset Turnover - - - - -
Leverage
Debt Ratio - 0.2 0.2 0.1 0.1
Debt – Equity Ratio 0.1 0.4 0.3 0.1 0.1
Interest Coverage -68 -13.6 -9.6 - -43
Equity multiplier 0.3 0.2 0.3 - -